Trade

with

AEterna Zentaris Inc
(NASDAQ: AEZS)
AdChoices
1.18
+0.05
+4.42%
After Hours :
1.18
0.00
0.00%

Open

1.14

Previous Close

1.13

Volume (Avg)

960.65k (1.07M)

Day's Range

1.14-1.19

52Wk Range

0.8200-1.74

Market Cap.

68.31M

Dividend Rate ( Yield )

-

Beta

1.50

Shares Outstanding

57.89M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 6.18M

    • Net Income

    • 6.82M

    • Market Cap.

    • 68.31M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -81,064.71

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.50

    • Forward P/E

    • -2.45

    • Price/Sales

    • 3,333.33

    • Price/Book Value

    • 6.67

    • Price/Cash flow

    • -2.41

      • EBITDA

      • -24.78M

      • Return on Capital %

      • -25.75

      • Return on Equity %

      • -152.79

      • Return on Assets %

      • -25.75

      • Book Value/Share

      • 0.18

      • Shares Outstanding

      • 57.89M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Outperform
        • 1 Year Price Target

        • 1.69

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 195.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -30.64

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -164,400.00

            • 39.38

            • Net Profit Margin

            • -81,064.71

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 49.90

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -139.30

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -29.70

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 0.95

              • 2.92

              • Quick Ratio

              • 0.93

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 5.28

              • 2.21

              • Book Value/Share

              • 0.18

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.80

                • 196.08

                • P/E Ratio 5-Year High

                • -25.67

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.31

                • 124.82

                • Price/Sales Ratio

                • 3,333.33

                • 9.12

                • Price/Book Value

                • 6.38

                • 8.26

                • Price/Cash Flow Ratio

                • -2.41

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -152.79

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -25.75

                    (-21.50)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -152.79

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.00

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -27.48M
                  Operating Margin
                  -444.96
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.41
                  Ownership

                  Institutional Ownership

                  1.55%

                  Top 10 Institutions

                  1.56%

                  Mutual Fund Ownership

                  0.05%

                  Float

                  99.86%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fortuna Select Mixte

                  •  

                    25,000

                  • 150.00

                  • 0.08

                  • Fidelity® Nasdaq Composite Tr Stk Fund

                  •  

                    1,554

                  • 9.44

                  • 0.00

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    1,514

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Renaissance Technologies Corp

                  •  

                    641,917

                  • +1,353.95%

                  • 1.14

                  • Aperio Group, LLC

                  •  

                    61,403

                  • 0.00%

                  • 0.11

                  • DAVENPORT vermogensbeheer

                  •  

                    25,000

                  • +150.00%

                  • 0.08

                  • Knight Capital Americas LLC

                  •  

                    22,476

                  • -23.70%

                  • 0.04

                  • Credit Suisse First Boston (CSFB)

                  •  

                    22,196

                  • -36.06%

                  • 0.04

                  • Tower Research Capital LLC

                  •  

                    21,828

                  • -49.39%

                  • 0.04

                  • Fifth Third Bancorp

                  •  

                    16,666

                  • 0.00%

                  • 0.03

                  • Morgan Stanley Smith Barney LLC

                  •  

                    12,102

                  • -15.38%

                  • 0.02

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Small Value

                  AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology.

                  Key People

                  David A. Dodd

                  President/CEO

                  Jurgen Ernst

                  Director/Chairman of the Board

                  Dennis Turpin

                  CFO/Senior VP

                  Pierre Lapalme

                  Director

                  Mr. Gerard A. Limoges

                  Director

                  • AEterna Zentaris Inc

                  • 1405 du Parc-Technologique Boulevard

                  • Quebec City, QC G1P 4P5

                  • CAN.Map

                  • Phone: +1 418 652-8525

                  • Fax: +1 418 948-9191

                  • aezsinc.com

                  Incorporated

                  1990

                  Employees

                  81

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: